pcf-39 and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

pcf-39 has been researched along with Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma* in 1 studies

1 other study(ies) available for pcf-39 and Precursor-Cell-Lymphoblastic-Leukemia-Lymphoma

Article	Year
In vivo antitumor activity of the hypoxanthine derivatives ST 789 and ST 689. Annals of the New York Academy of Sciences, 1993, Jun-23, Volume: 685 Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Arginine; Cell Division; Humans; Hypoxanthines; Interleukin-6; Macrophages; Male; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured	1993